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Abstract
Background: The prevention of unintended pregnancies among HIV positive women is a neglected strategy in
the fight against HIV/AIDS. Women who want to avoid unintended pregnancies can do this by using a modern
contraceptive method. Contraceptive choice, in particular the use of long acting and permanent methods (LAPMs),
is poorly understood among HIV-positive women. This study aimed to compare factors that influence women’s
choice in contraception and women’s knowledge and attitudes towards the IUD and female sterilization by HIV-
status in a high HIV prevalence setting, Cape Town, South Africa.
Methods: A quantitative cross-sectional survey was conducted using an interviewer-administered questionnaire
amongst 265 HIV positive and 273 HIV-negative postpartum women in Cape Town. Contraceptive use,
reproductive history and the future fertility intentions of postpartum women were compared using chi-squared
tests, Wilcoxon rank-sum and Fisher’s exact tests where appropriate. Women’s knowledge and attitudes towards
long acting and permanent methods as well as factors that influence women’s choice in contraception were
examined.
Results: The majority of women reported that their most recent pregnancy was unplanned (61.6% HIV positive
and 63.2% HIV negative). Current use of contraception was high with no difference by HIV status (89.8% HIV
positive and 89% HIV negative). Most women were using short acting methods, primarily the 3-monthly injectable
(Depo Provera). Method convenience and health care provider recommendations were found to most commonly
influence method choice. A small percentage of women (6.44%) were using long acting and permanent methods,
all of whom were using sterilization; however, it was found that poor knowledge regarding LAPMs is likely to be
contributing to the poor uptake of these methods.
Conclusions: Improving contraceptive counselling to include LAPM and strengthening services for these methods
are warranted in this setting for all women regardless of HIV status. These study results confirm that strategies
focusing on increasing users’ knowledge about LAPM are needed to encourage uptake of these methods and to
meet women’s needs for an expanded range of contraceptives which will aid in preventing unintended
pregnancies. Given that HIV positive women were found to be more favourable to future use of the IUD it is
possible that there may be more uptake of the IUD amongst these women.
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Prevention of mother-to-child transmission (PMTCT)
o fH I Vh a sb e e nag l o b a lp r i o r i t ys i n c et h el a t e1 9 9 0 ’s
[1]. Although great progress has been made in prevent-
ing vertical transmission of HIV, nearly half a million
children worldwide were newly infected in 2008, of
which 90% were as a result of mother-to-child trans-
mission [1]. The World Health Organization (WHO)
promotes a four element strategy for PMTCT of HIV:
preventing HIV infection among women, preventing
unintended pregnancies, preventing perinatal HIV
infection through use of antiretroviral prophylaxis, and
providing care and support to HIV positive mothers
and their families [1]. The prevention of unintended
pregnancies among HIV positive women, although
highly cost-effective, is a neglected strategy in the fight
against HIV/AIDS [2,3].
In South Africa, an estimated 5.2 million people are
infected with HIV and women are disproportionately
affected [4]. The prevalence of HIV in South Africa has
been found to peak among females aged 25-29 years at
32.7% [4]. The Western Cape is the province with the
lowest HIV prevalence rates in South Africa although,
compared to the rest of the world, the prevalence of
HIV (5.3%) among 25-49 year old women [4] is high. In
sections of Cape Town with high concentration of low
income populations, over 25% of women seeking
antenatal care are HIV positive [5]. Thus PMTCT
among sexually active HIV positive women is an impor-
tant component in the fight against HIV/AIDS in this
region. Prior research in South Africa and elsewhere in
sub-Saharan Africa has shown that many HIV-positive
women desire pregnancy, although for some HIV status
does diminish aspirations for childbearing [6,7].
Focusing specifically on those HIV positive women
who currently want to avoid pregnancy, this intention
can be achieved by using a modern contraceptive
method. Counselling must be offered in an environment
free of coercion and in a way that ensures the client has
sufficient knowledge about the full range of contracep-
tive options to make an informed choice of the method
that optimally suits her needs [8]. Evidence is largely
lacking, however, on how family planning services can
be tailored to meet the needs of HIV-positive women,
given that little research has systematically examined
how contraceptive knowledge and beliefs vary by sero-
status. Studies among HIV positive women have identi-
fied male condoms as being the most popular method
of contraception, followed by hormonal methods; use of
IUDs is rare [9-11]. Method choice has been found to
be influenced by previous method use and the need for
methods that can be started immediately after delivery
[9]. In research conducted in South Africa, one study
showed higher contraceptive prevalence among women
living with HIV compared to their HIV-negative coun-
terparts [12], while another study conducted with post-
partum women showed no such difference [13]. A study
with postpartum women in Rwanda found greater con-
traceptive use among HIV-positive women, along with
greater knowledge of modern contraceptive methods
[14].
In offering contraceptive services to all women,
regardless of sero-status, expanding the range of avail-
able methods has been shown to increase both contra-
ceptive prevalence [15,16], and continuation rates [17].
One approach for increasing contraceptive options is
to promote and ensure access to long-acting and per-
manent methods (LAPM) in addition to short-acting
methods like condoms, injectables, and oral contracep-
tives. Long-acting methods like the IUD and implants
and permanent methods like male and female steriliza-
tion are not dependent on users’ adherence. Addition-
ally, continuation does not require repeated contact
with health care providers. These two factors make
LAPMs more effective than short-acting methods in
preventing pregnancies among typical users. Despite
high motivation to avoid pregnancy among many HIV-
positive women and desire for highly effective contra-
ception, use of LAPMs is typically low [14]. Expanding
method choice beyond short acting hormonal methods
m a yb e c o m ei n c r e a s i n g l yi m p o r t a n ti nl i g h to fn e w
data suggesting a potential link between hormonal
contraceptive use and HIV acquisition and transmis-
sion [18].
Modern contraceptive methods are available free of
charge at public sector health care facilities in South
Africa, and use is high: an estimated 65% of sexually
active women use a method [19]. The majority of sexu-
ally active women in South Africa use short acting
methods–primarily injectable contraceptives (33.2%)
with 10% of women using female sterilization and less
than 1% using the intrauterine device (IUD) [19]. Weak
promotion and uptake of LAPMs in South Africa,
including among HIV positive women who report that
they desire no future pregnancies, has been identified as
a gap in service provision [8,13,20].
This cross sectional study examined factors that influ-
enced HIV positive and negative women’s choice in con-
traception, focusing primarily on knowledge and
attitudes towards the IUD and female sterilization, the
two LAPMs currently available in South African public
sector facilities. The study examined whether differences
exist between the two populations in terms of factors
influencing method choice, with the aim of determining
how services could be adapted to respond to the contra-
ceptive needs of HIV positive women.
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Study design and setting
The data for this study were derived from a pre-interven-
tion quantitative cross sectional survey undertaken to
evaluate knowledge, attitudes, and behaviours related to
use of LAPM. Data were collected via face-to-face inter-
views at four public sector primary care facilities in
Khayelitsha and one clinic in Mitchell’s Plain in the
greater Cape Town area. Selected sites offered both
PMTCT and family planning services and had the neces-
sary infrastructure and staffing to offer IUD services.
Khayelitsha and Mitchell’s Plain are high density areas
situated on the outskirts of Cape Town. Poverty and
unemployment are high in these areas. Khayelitsha has a
very high burden of HIV with 30.1% of women attending
antenatal care testing positive [21,22]. Antenatal HIV
prevalence in the Mitchell’s Plain district is 13.9% [21].
Sample
Eligible study participants were women seeking child
health services for an infant 6 months or younger and
who received antenatal care during their most recent
pregnancy. Potential participants were identified in the
waiting areas at primary health care clinics. Those who
were eligible were invited to participate in the order in
which they presented at the facility until the intended
sample size was achieved. Participants were excluded if
they were younger than 18 years of age or could not
understand English or Xhosa.
The study aimed to interview 250 women who had
used PMTCT services and an equal number of postpar-
tum women who had not used such services, who were
presumed to be HIV negative. This sample size, to be
repeated post-intervention, provides sufficient power to
determine whether the intervention was a success,
defined as at least 30% of HIV-positive participants
expressing correct knowledge about the IUD and female
sterilization as a contraceptive option.
Data collection
Trained research assistants administered structured ques-
tionnaires collecting information on socio-demographic
characteristics, contraceptive use, reproductive history and
future fertility intentions. The questionnaire also included
items on women’s exposure to LAPM counselling postpar-
tum and the content of this counselling. Further questions
were asked regarding women’s knowledge and attitudes
towards the IUD and female sterilization as LAPM. Data
collection took place from February to May 2009.
Data analysis
Data were analysed using STATA 10.0 [23]. Summary
statistics were estimated separately for HIV positive and
HIV negative participants. Descriptive results were com-
pared by HIV status using chi-squared tests or Fisher’s
exact tests for categorical outcomes and Wilcoxon rank-
sum tests for continuous outcomes.
Ethics
The research was approved by the Health Science
Faculty Human Research Ethics Committee of the Uni-
versity of Cape Town (235/2008) as well as by the Wes-
tern Cape Department of Health (19/18/RP53/2008) and
the Protection of Human Subjects Committee of FHI
360. All participants gave written informed consent
before enrolment took place.
Results
Socio-demographic characteristics
The demographic profiles of the HIV positive and nega-
tive participants were similar (Table 1). Participants
were most commonly in their mid-twenties, unem-
ployed, had less than a grade 12 education, were unmar-
ried but in a stable relationship and had an average of
two living children.
Pregnancy history and fertility desires
The majority of women in both samples reported their
most recent pregnancy was unintended (not planned)
(Table 1). Significantly more (p < 0.001) HIV positive
w o m e ne i t h e rd i dn o tw a n ta n o t h e rc h i l do rw e r e
unsure whether they wanted another child. Of all the
women who expressed interest in having another child,
the vast majority wanted to wait at least three years or
were unsure of when they wanted their next child.
Current use of contraception
Nearly ninety per cent of HIV positive and HIV negative
participants reported that they were currently using a
modern method of contraception (Table 2). The vast
majority of women in both samples were using short
acting methods, primarily the 3-monthly injectable,
Depo Provera (DMPA). No IUD use was reported, and a
similarly small percentage of participants reported they
had undergone female sterilization. A small percentage
of women (3.8% HIV positive and 1.7% HIV negative)
were using condoms in addition to a hormonal method
of contraception or sterilization (data not shown).
Table 2 presents participants’ reasons for contraceptive
choice, stratified by HIV status and method category
(hormonal versus sterilization; no IUD use was reported).
The four most common reasons given for hormonal
method choice were: convenience, provider recommen-
dation, absence of side effects and method effectiveness
in preventing pregnancy. While these reasons were most
commonly mentioned in both samples, significantly more
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method choice was based on its effectiveness in prevent-
ing pregnancy. Furthermore ‘provider recommended the
method’ was significantly different for hormonal method
choice, with a greater percentage of HIV negative women
stating this as a reason. The most commonly mentioned
reason for choice of female sterilization in both samples
was convenience; most HIV-negative women also men-
tioned high effectiveness as a factor influencing choice of
sterilization. While there were no significant differences
between the two samples for their choice of female steri-
lization notable percentage differences can be seen. A
greater percentage of HIV negative women stated that
their reason for choosing female sterilization was due to
its effectiveness in preventing pregnancy, while more
than double the number of HIV positive women men-
tioned that their choice was based on provider
recommendation.
Table 1 Summary characteristics, including reproductive history and fertility desires of postpartum HIV positive and
negative women attending child health services
Characteristic HIV Positive n = 265 HIV Negative n = 273 P-value*
n%n %
Age Median (IQR) 27 (23-32) 25 (21-29) 0.144
Highest level of education† 0.332
No formal schooling 0 0.0% 0 0.0%
Grade 1-7 19 7.2% 16 5.9%
Grade 8-12 without matric 171 64.8% 173 63.4%
Grade 12 with matric 66 25.0% 66 24.2%
Tertiary qualification 8 3.1% 18 6.6%
Current relationship status‡ 0.274
Married 88 33.3% 93 34.7%
Single, stable relationship 166 62.9% 160 59.7%
Single, casual relationship 2 0.8% 8 3.0%
Single, no relationship 8 3.0% 7 2.6%
Employment status 0.844
Paid Job (Yes) 66 24.9% 70 25.6%
Paid Job (No) 199 75.1% 203 74.4%
Number of living children Median (IQR) 2(1-2) 2(1-2) 0.632
Time since delivery (months) Median (IQR) 2.20 (1.28-3.43) 2.40 (1.48-3.38) 0.049
Last pregnancy intended§ 0.696
Yes 101 38.4% 100 36.8%
No 162 61.6% 172 63.2%
Would like another child < 0.001
Yes 30 11.3% 74 27.1
No 194 73.2% 168 61.5%
Unsure 41 15.5% 31 11.4%
n = 30 n = 74
Desired timing of next child
ǁ 0.684
< 12 months 0 0% 0 0%
12-24 months 1 3.3% 3 4.2%
25-36 months 3 10% 6 8.3%
> 36 months 13 43.3% 40 55.6%
Unsure 13 43.3% 23 31.9%
Missing values excluded from denominators in calculation of percentages.
*P-values for comparisons using Wilcoxon sum-rank and chi-squared tests
†One missing value in HIV+
‡Two missing values in HIV + and five missing values in HIV-,
§ Two missing values in HIV + and one missing value in HIV-
ǁTwo missing values in HIV-
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regarding LAPM
Participants were asked whether a provider had talked
to them about family planning methods in the time
since last becoming pregnant. A greater proportion of
HIV negative women reported that a provider had dis-
cussed family planning methods, with just under half of
HIV positive women reporting exposure to such mes-
sages (Table 3). Similarly few women in both samples
reported being told about the IUD. More participants
reported that a provider had told them about female
sterilization since last becoming pregnant, with no dif-
ference between the two groups. Most commonly this
information was presented to participants in a group
(51.2%- data not shown in table).
T h en u m b e ro fw o m e nr e p o r t i n gt h a tt h e yw e r ei n
favour of the IUD, when asked whether their overall opi-
nion about the IUD was favourable or unfavourable, was
significantly greater (p = 0.001) among HIV positive
(79.3%) than HIV negative (68.9%) participants. Reasons
for not wanting to use the IUD among women unwilling to
try the method in the future are presented in Table 3. Sig-
nificantly more (p = 0.021) HIV positive women reported
that they would not use the IUD in future as they were not
sure if it was safe to use with their current health status
(20.5% HIV positive vs. 3.9% HIV negative). In contrast,
participants’ overall opinion of sterilization was similar and
favourable for 75.9% of HIV positive participants and
71.8% of HIV negative participants (Table 3). Looking at
the reasons for not using sterilization in the future, signifi-
cantly more HIV negative women stated that method per-
manence and lack of information about the method were
their reasons for not wanting to use sterilization. For both
the IUD and female sterilization concerns regarding the
procedures involved were identified as reasons why women
do not want to use these methods in the future (Table 3).
When asked how an HIV positive woman can avoid
transmitting HIV to her infant, the most common
answer among both HIV positive and negative women
was by attending PMTCT services offering antiretroviral
prophylaxis for the woman and the newborn (86.4%
HIV positive and 72.2% HIV negative) (Data not
s h o w n ) .I na d d i t i o ns i g n i f i c a n t l ym o r eH I Vn e g a t i v e
women (30.0% versus 21.5%, p = 0.002) reported that
avoiding pregnancy would aid in the prevention of
mother to child transmission.
In response to the six questions asked to determine
women’s knowledge about the IUD as a LAPM, more
than half of all participants, both HIV positive and nega-
tive, either did not know or were unsure that: women
doing well on antiretrovirals (ARVs) can use an IUD;
that breastfeeding women can use the IUD; that changes
in bleeding patterns are a possible side effect of the IUD
or that the IUD is effective in preventing pregnancy for
10 years (Figure 1).
Five questions were asked to ascertain women’s
knowledge about sterilization. More than 90% of women
in both samples knew that sterilization should only be
Table 2 Use of contraception and most common reasons
reported for method choice by type of contraceptive
method currently using
HIV
Positive
n = 265
HIV
Negative
n = 273
P-
value*
n (%) n (%)
Currently using a family planning method 0.763
Yes 238 89.8% 243 89.0%
No 27 10.2% 30 11.0%
n = 238 n = 243
Method currently used
IUD 0 0% 0 0% N/A
Male Sterilization 0 0% 1 0.4% N/A
Female Sterilization 17 7.1% 14 5.8% 0.537
Condoms† 13 5.5% 6 2.5% 0.105
Pills 2 0.8% 6 2.5% 0.285
2 monthly injectable 48 20.2% 59 24.3% 0.278
3 monthly injectable 167 70.2% 160 65.8% 0.309
Hormonal methods
(Injectables and Pills)
HIV
Positive
n = 217
HIV
Negative
n = 225
Reason for hormonal method choice§
Method is convenient for me 110 50.7% 99 44% 0.159
Provider recommended the
method
106 48.9% 133 59.1% 0.030
No side effects 18 8.3% 30 13.3% 0.089
Effective in preventing
pregnancy
12 5.5% 25 11.1% 0.034
Partner approves of method 0 0% 1 0.5% N/A
Female sterilization
HIV
Positive
n=1 7
HIV
Negative
n=1 4
Reason for female sterilization method choice§
Method is convenient for me 15 88.2% 10 71.4% 0.370
Effective in preventing
pregnancy
7 41.2% 10 71.4% 0.149
Provider recommended the
method
5 29.4% 2 14.3% 0.412
Partner approves of method 4 23.5% 4 28.6% 1.00
No side effects 0 0% 2 14.3% 0.196
*P-values for bi-variate comparisons using Chi-squared test or Fisher’s exact
test
†Includes use of male and female condoms
§Respondents could name more than one reason; this table presents the four
most common reasons for each method group.
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(Figure 2). Half the HIV negative participants and 44.1%
of HIV positive participants did not know or were
unsure that sterilization is a more effective method of
contraception than the injection.
Discussion
This study documented low use of the IUD and female
sterilization among postpartum women seeking child
health services for their infants in public sector facilities,
with negligible difference based on HIV status. This
Table 3 Exposure to IUD or sterilization counselling and attitudes among women unwilling to try the method in the
future†
HIV Positive HIV Negative P-value*
n (%) n (%)
n = 265 n = 273
Counselled by provider on family planning methods
Yes 128(48.3%) 160(58.6%) 0.017
No 137(51.7%) 113(41.4%)
n = 128 n = 160
Counselled by provider on IUD †
Yes 10(7.8%) 16(10.0%) 0.520
No 118(92.2%) 144(90.0%)
Overall opinion of IUD
Favourable 210(79.3%) 188(68.9%) 0.001
Unfavourable 34(12.8%) 70(25.6%)
No opinion 21(7.9%) 15(5.5%)
n = 44 n = 52
Reasons for not using IUD in future ‡
Prefer sterilization/already sterilized 11(25.0%) 13(25.0%) 1.00
Concern about/Fear of Insertion and removal procedure 9(20.5%) 11(21.2%) 0.933
Not sure if safe with current health status 9(20.5%) 2(3.9%) 0.021
More info needed 5(11.4%) 4(7.7%) 0.728
Don’t know enough or scared 4(9.1%) 4(7.7%) 1.00
Unsure 5(11.4%) 8(15.4%) 0.766
n = 128 n = 160
Counselled by provider on female sterilization†
Yes 74(57.8%) 74(46.3%) 0.051
No 54(42.2%) 86(53.8%)
Overall opinion of Sterilization
Favourable 201(75.9%) 196(71.8%) 0.561
Unfavourable 43(16.2%) 51(18.7%)
No opinion 21(7.9%) 26(9.5%)
n = 57 n = 80
Reasons for not using sterilization in future §
Permanent 30(52.6%) 57(71.3%) 0.026
Surgical procedure 10(17.5%) 22(27.5%) 0.175
Too young/not married 18(31.6%) 25(31.3%) 0.967
Need more information 3 (5.3%) 16(20.0%) 0.014
Afraid of procedure 13(22.8%) 16(20.0%) 0.692
No protection against STIs and HIV 3(5.3%) 3(3.8%) 0.693
*P-values for comparisons using Chi-squared and Fisher’s exact
†Denominator is women who received family planning counselling
‡Participants could report several reasons; those shown where n > 5. Denominator is women not willing to try the IUD in the future
§Participants could report several reasons; those shown where n > 5. Denominator is women not willing to try female sterilization in the future.
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conducted prior to an intervention to strengthen pro-
motion and provision of an expanded range of contra-
ceptive options, including long acting and permanent
methods. More surprising was the finding that the large
majority of interviewed women were already using
injectable contraceptives, despite being on average just
over 2 months postpartum. High reliance on injectables
likely reflects the practice of some of South Africa’s
public sector facilities to offer injectables immediately
post-delivery; it also mirrors contraceptive method pat-
terns among South African women in general [19].
The study results suggest high potential demand for
highly effective, long acting and permanent methods of
family planning that enable women to space their chil-
dren or to avoid pregnancy entirely, according to their
desires. Most women interviewed reported that their
most recent pregnancy was not planned. Amongst the
HIV positive women nearly three quarters wanted to
avoid a future pregnancy. Of interview participants who
did want a future pregnancy, more than 80% wanted to
wait at least 36 months before their next pregnancy. For
some women who have achieved their desired family
size or who are highly motivated to avoid pregnancy,
injectable contraceptives may not be the ideal method
choice. Method effectiveness depends on the client mak-
ing timely visits to a health service provider four to six
times per year for re-injection; women’ss u c c e s sw i t h
the method also depends on facilities maintaining con-
sistent supplies. Prior research in South Africa has
revealed the substantial number of injectable users who
return late for re-injections, leading some to suspend at
least temporarily use of any method [24].
This study revealed knowledge gaps and biases that
must be addressed in efforts to increase use of LAPM.
The results show a substantial gap between the propor-
tion of women saying they are in favour of LAPM and
the proportion actually using them. Even though signifi-
cantly more HIV positive women were in favour of the
IUD, among women saying they would not use the IUD
in the future, significantly more HIV positive women
stated as a reason that they were not sure it was safe
given their health status.
Of importance, particularly in high HIV prevalence
settings, is that the IUD can be used on clinically well
HIV positive women [25]. This message needs to be
communicated to all participants during contraceptive
counselling. In addition, many women did not want to
use LAPM in the future due to concerns about the pro-
cedures involved and the fear associated with these pro-
cedures. Women’s fear of invasive procedures poses a
challenge in encouraging the uptake of the IUD and
sterilization. However, most women interviewed did not
have sufficient knowledge about LAPM to make a fully
informed method choice. Participant knowledge of steri-
lisation was greater than that regarding IUDs in this
study, probably owing to the presence of sterilisation
services in the Western Cape and the lack of IUD pro-
motion and use. Yet for both the IUD and sterilization,
“needing more information” was a reason given for not
intending to use these LAPMs in the future. The lack of
knowledge regarding the IUD, in particular, is evident
where question after question were answered incorrectly
or women stated that they were unsure about the cor-
rect answer. This suggests that counselling on the full
range of available contraceptives was ineffective at the
time of the survey.
The permanence of female sterilization was identified
by 63.5% of interviewed women as a reason for not
wanting to undergo the procedure, reasoning that must
be fully respected. Other long acting methods such as
the IUD should be offered as a possible alternative. The
IUD is a method that is more than 98% effective in pre-
venting pregnancy [26] and allows a quick return to fer-
tility after removal thus allowing women to plan and
space their children effectively. A woman using the IUD
is not required to attend repeat follow up visits at the
clinic and thus this method can be seen as convenient.
Figure 1 Women’s knowledge about the IUD.
Figure 2 Women’s knowledge about sterilization.
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use of hormonal methods, among the study sample, was
that the method was convenient. Thus the convenience
of LAPM should be communicated to women during
counselling if this is a determining factor in their choice
of method. It can be seen that the IUD provides a highly
effective and convenient method to HIV-positive and
-negative women wanting to plan their families and
space their children. To maximize service effectiveness,
family planning services must capitalize more on the
safe, effective technologies that already exist but which
are not easily accessible to participants.
Our findings revealed the important influence that
health care providers have over women’s use of contra-
ceptive methods. Only about half of all participants
reported having been told by a provider about contra-
ceptive methods since last becoming pregnant, HIV
positive women being even less likely to be so informed.
These results raise questions as to whether the recom-
mended education regarding healthy timing and spacing
of children is being adequately addressed in postpartum
health care services and whether women are given suffi-
cient method choice. Furthermore as only a small frac-
tion of participants were informed about the IUD and
52% overall were counselled on sterilization it is ques-
tionable whether the full range of contraceptive methods
are available and promoted in all services targeting preg-
nant and postpartum women. Meanwhile, 55.1% of
injectable users stated that a reason for method choice
was because a provider recommended it. This finding is
consistent with other studies where provider related fac-
tors influenced method choice [27]. Women in all com-
munities should have access to the full range of
methods available in the public health care setting to
enable them to choose the most suitable method and to
promote consistent and correct use. If women do not
have access to the full range of available contraceptive
methods this may result in women using methods that
are known to have relatively high failure rates amongst
typical users [27]. Through expanding contraceptive
options the gap between women’s reported childbearing
intentions and actual childbearing would be able to be
narrowed [28].
Conclusions
The high rates of unintended pregnancies in the sam-
ple of HIV positive women suggest that the WHO’s
strategy of preventing unintended pregnancies
amongst HIV positive women to minimise vertical
transmission of HIV must be reinforced. Long acting
and permanent methods could fill an important gap in
family planning services in South Africa given
women’s stated fertility preferences indicating a strong
desire to either not have a future pregnancy or to wait
several years before the birth of their next child.
Given the high contraceptive prevalence recorded in
the target population, half of whom were PMTCT par-
ticipants, the challenge in providing services lies not in
encouraging timely postpartum family planning
uptake; rather, it lies in encouraging consideration of
an expanded range of contraceptive options, including
LAPM.
Future efforts must focus on increasing women’s
knowledge about safe, effective and long-acting contra-
ceptive options, thereby preparing them to make a fully
informed method choice. This can be achieved by
strengthening providers’ capacity to promote and deliver
an expanded range of contraceptive methods and estab-
lishing provision of such comprehensive services as a
standard performance expectation. The similar rates of
unintended pregnancies, similar reasons for contracep-
tive method choice and similar knowledge and attitudes
about LAPM between HIV positive and negative women
highlight the need for improved family planning coun-
selling for all women. Initiatives focused on serving the
postpartum family planning needs of PMTCT partici-
pants should focus first on resolving challenges asso-
ciated with facilitating uptake of highly effective and
permanent contraceptive methods by all women, regard-
less of HIV status.
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